Clinical Trials Directory

Trials / Completed

CompletedNCT02407262

Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
80 (actual)
Sponsor
University College, London · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Traditionally, Black Seed (Nigella sativa) is a well-known food supplement and herbal product that has a wide range of medical claims (including asthma) that originate from different historical backgrounds. Today in the era of Evidence-based medicine, it is hard to accept those traditional medical claims of medicinal plants without valid scientific experiments. Thus, randomized clinical trials is important to rational the uses of herbal products. Asthma is a common chronic disorder of the airways, characterized by variable reversible and recurring symptoms related to airflow obstruction, bronchial hyper-responsiveness, and underlying inflammation. In Saudi Arabia, Asthma is considered one of the leading chronic diseases affecting more than 2 million Saudi citizens. The global Asthma Report 2014 considered Asthma as an epidemic disease probably affecting about 334 million people worldwide and becoming a global health priority. This project investigates the use of herbal products to enhance asthma control in Saudi Arabia. In this context, Black Seed is one of the common herbal products used traditionally for asthma in the Saudi region. Black seed is a common unconventional therapy used among 10% of Asthmatic patients in King Abdulaziz Medical city, Riyadh. In fact, there are some pre-clinical evidence and preliminary clinical studies support the usefulness of Black seed in Asthma and its underlying causes

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBlack seed oil
OTHERPlacebovegetable oil

Timeline

Start date
2015-05-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-04-02
Last updated
2016-05-12

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT02407262. Inclusion in this directory is not an endorsement.